Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

LENZ Therapeutics

Tracked across 1 events · 6 articles · First seen Sep 01, 2026 · Last active Sep 05, 2026

Sentiment
-70
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 -70
Regulatory
Pomerantz LLP announced it is investigating claims on behalf of investors of LENZ Therapeutics, Inc. (Nasdaq: LENZ) concerning whether the company and certain officers and/or directors engaged in securities fraud or other unlawful business practices.…
Impact: LENZ Therapeutics is the subject of the investigation and experienced a sharp stock price decline following its Q2 results and the downgrade. The company faces potential securities fraud claims and reputational damage.
Sep 01, 2026 · 6 articles
ERGEN INTELLIGENCE
Track LENZ Therapeutics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.